Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,221 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[No title available]
[No authors listed] [No authors listed] PMID: 38117390
Five-year analysis of neoadjuvant dabrafenib and trametinib for stage III melanoma.
Menzies AM, Lo SN, Saw RPM, Gonzalez M, Ch'ng S, Nieweg OE, Shannon KF, Ferguson PM, Lee J, Emmett L, Kapoor R, Rawson RV, Stretch JR, Thompson JF, Spillane AJ, Rizos H, Scolyer RA, Long GV. Menzies AM, et al. Among authors: thompson jf. Ann Oncol. 2024 May 14:S0923-7534(24)00141-8. doi: 10.1016/j.annonc.2024.05.002. Online ahead of print. Ann Oncol. 2024. PMID: 38754780
ASO Visual Abstract: The Effect of Neoadjuvant Systemic Therapy on Surgical Outcomes After Lymph Node Dissections for Stage III Melanoma: An Australian Cohort.
Zijlker LP, Chen H, Spillane AJ, Gonzalez M, Pennington TE, Menzies AM, Lo SN, Ferguson P, Rawson R, Colebatch AJ, Stretch JR, Thompson JF, Ch'ng S, Nieweg O, Shannon KF, Long GV, Scolyer RA, Saw RPM, van Akkooi ACJ. Zijlker LP, et al. Among authors: thompson jf. Ann Surg Oncol. 2024 May 17. doi: 10.1245/s10434-024-15348-z. Online ahead of print. Ann Surg Oncol. 2024. PMID: 38758487 No abstract available.
The Effect of Neoadjuvant Systemic Therapy on Surgical Outcomes After Lymph Node Dissections for Stage III Melanoma; An Australian Cohort.
Zijlker LP, Chen H, Spillane AJ, Gonzalez M, Pennington TE, Menzies AM, Lo SN, Ferguson P, Rawson R, Colebatch AJ, Stretch JR, Thompson JF, Ch'ng S, Nieweg O, Shannon KF, Long GV, Scolyer RA, Saw RPM, van Akkooi ACJ. Zijlker LP, et al. Among authors: thompson jf. Ann Surg Oncol. 2024 May 18. doi: 10.1245/s10434-024-15274-0. Online ahead of print. Ann Surg Oncol. 2024. PMID: 38762644
Smoking Status and Survival in Patients With Early-Stage Primary Cutaneous Melanoma.
Jackson KM, Jones PC, Fluke LM, Fischer TD, Thompson JF, Cochran AJ, Stern SL, Faries MB, Hoon DSB, Foshag LJ. Jackson KM, et al. Among authors: thompson jf. JAMA Netw Open. 2024 Feb 5;7(2):e2354751. doi: 10.1001/jamanetworkopen.2023.54751. JAMA Netw Open. 2024. PMID: 38319662 Free PMC article. Clinical Trial.
Genomic Classification of Cutaneous Melanoma.
Cancer Genome Atlas Network. Cancer Genome Atlas Network. Cell. 2015 Jun 18;161(7):1681-96. doi: 10.1016/j.cell.2015.05.044. Cell. 2015. PMID: 26091043 Free PMC article.
Regarding sentinel lymph node biopsy in younger and older patients.
Faries MB, Varey A, Elashoff DA, Lo S, Thompson JF. Faries MB, et al. Among authors: thompson jf. J Eur Acad Dermatol Venereol. 2024 Jun 1. doi: 10.1111/jdv.20162. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38822601 No abstract available.
Development and validation of a novel model to predict recurrence-free survival and melanoma-specific survival after sentinel lymph node biopsy in patients with melanoma: an international, retrospective, multicentre analysis.
Stassen RC, Maas CCHM, van der Veldt AAM, Lo SN, Saw RPM, Varey AHR, Scolyer RA, Long GV, Thompson JF, Rutkowski P, Keilholz U, van Akkooi ACJ, Verhoef C, van Klaveren D, Grünhagen DJ. Stassen RC, et al. Among authors: thompson jf. Lancet Oncol. 2024 Apr;25(4):509-517. doi: 10.1016/S1470-2045(24)00076-7. Lancet Oncol. 2024. PMID: 38547894
1,221 results